New drug targets and small molecules for promoting cardiac regeneration
Bidragets beskrivning
Currently, there is no effective drug treatment for post-infarction heart failure, which is a major public health issue and a huge economic burden. The adult human heart cannot repair the tissue injury caused by myocardial infarction, and the loss of cardiomyocytes leads to the development of heart failure. Remarkably, zebrafish and neonatal rodents can regenerate their hearts. This involves generation of new blood vessels and proliferation of existing cardiomyocytes, but the mechanisms regulating these phenomena are not fully understood. By elucidating endogenous mechanisms of cardiac regeneration, this work aims to identify new drug targets for cardiac regeneration-inducing therapies and develop small molecule compounds with potential cardiac regeneration-enhancing activity.
Visa merStartår
2019
Slutår
2024
Beviljade finansiering
Andra beslut
353109
Akademiforskarens forskningskostnader(2022)
200 000 €
328909
Akademiforskarens forskningskostnader(2019)
300 000 €
Finansiär
Finlands Akademi
Typ av finansiering
Akademiforskare
Utlysning
Övriga uppgifter
Finansieringsbeslutets nummer
321564
Vetenskapsområden
Farmaci
Forskningsområden
Farmasia
Identifierade teman
cardiovascular diseases